/Companies

Calcivis

Edinburgh, GB · Founded 2011 · United Kingdom corporation · 7 known investors

Find your way into Calcivis

Sign up to see every warm intro you have to Calcivis

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Calcivis team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry. The FDA-approved and UKCA-marked system is aimed at dental clinicians managing caries and erosion.

Founders & leadership

GMGregory M. Sheehan
Gregory M. SheehanCEO
JMJill McGregor
Jill McGregorCOOCOO of Calcivis, a developer of a chairside diagnostic imaging system for dental caries assessment. McGregor has 15 years of experience in finance and operations roles at technology companies, including CFO positions at AIM-listed and private firms where she managed IPOs, acquisitions, and capital raises.
BV
Bruce VernonCo-founder & CTO
PA
Peter Anthony ReesNamed on SEC filing
AC
Adam ChristieCo-founder & CEO
JJ
James Jonathan BrowningNamed on SEC filing

Investors · 7

Also in the syndicate · 1

IFS Maven Equity Finance

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 3 of 4 rounds · 2014–2024

▶$792KraisedAug 2018 · 1 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • BRUCE VERNONDirector
  • JAMES JONATHAN BROWNINGDirector
  • ZISHAN AHMAD HAROONDirector
  • PETER ANTHONY REESDirector
  • ADAM CHRISTIEDirector
Offering amount
$792K
Amount sold
$792K
Minimum investment
$749K
First sale
Jul 2018
Incorporated
Corporation, United Kingdom
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.3MraisedOct 2017 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce VernonDirector
  • Peter Anthony ReesDirector
  • Adam ChristieDirector
  • James Jonathan BrowningDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Sep 2017
Incorporated
Corporation, United Kingdom
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$109.7KraisedMar 2014 · 1 investors · Other Health Care
Officers, directors & promoters on the filing
  • BRUCE VERNONDirector
  • JAMES JONATHAN BROWNINGDirector
  • ADAM CHRISTIEDirector
Offering amount
$109.7K
Amount sold
$109.7K
Minimum investment
$109.7K
Proceeds to insiders
$209.2K
First sale
Mar 2014
Incorporated
Corporation, United Kingdom, 2011
Federal exemptions
05
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as Calcivis.

Companies House · registry record

View on Companies House ↗
Registered name
CALCIVIS LIMITED
Company number
SC403657
Status
Active
Company type
Private limited company
Incorporated
18 Jul 2011
Registered office
9 Edinburgh Bioquarter, Little France, Edinburgh, Midlothian, EH16 4UX
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 31 Dec 2024 · next due 30 Sept 2026
Confirmation statement
last made up to 16 Jul 2026 · next due 30 Jul 2027

Current officers · 3

  • Simon Timothy Jackson — director, appointed 1 Jul 2024
  • Jill Amanda Mcgregor — director, appointed 21 Nov 2024
  • Gregory Matthew Sheehan — director, appointed 1 May 2025

Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Calcivis do?
CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry. The FDA-approved and UKCA-marked system is aimed at dental clinicians managing caries and erosion.
Who are Calcivis's investors?
Calcivis's investors include Archangels, Scottish National Investment Bank, British Business Bank, Maven Capital Partners, Scottish Enterprise, Scottish Investment Bank.
How much funding has Calcivis raised?
Calcivis has disclosed $2.2M raised across 3 of its 4 known rounds.
Where is Calcivis headquartered?
Calcivis is headquartered in Edinburgh, GB.